Skip to main content
Top
Published in: International Journal of Clinical Oncology 1/2008

01-02-2008 | Case Report

A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene

Authors: Naohiro Izawa, Seiichi Matsumoto, Jun Manabe, Taisuke Tanizawa, Manabu Hoshi, Toshio Shigemitsu, Rikuo Machinami, Hiroaki Kanda, Kengo Takeuchi, Yoshio Miki, Masami Arai, Shuya Shirahama, Noriyoshi Kawaguchi

Published in: International Journal of Clinical Oncology | Issue 1/2008

Login to get access
Metadata
Title
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
Authors
Naohiro Izawa
Seiichi Matsumoto
Jun Manabe
Taisuke Tanizawa
Manabu Hoshi
Toshio Shigemitsu
Rikuo Machinami
Hiroaki Kanda
Kengo Takeuchi
Yoshio Miki
Masami Arai
Shuya Shirahama
Noriyoshi Kawaguchi
Publication date
01-02-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 1/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0692-8

Other articles of this Issue 1/2008

International Journal of Clinical Oncology 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine